Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T&R Biofab CoXKRX:246710 -0.68%57 Days Payable is 11.73 as of Jun. 2026, which is 37% above its 10-year median of 8.55. GuruFocus rates XKRX:246710 with a GF Score™ of 57/100 and a GF Value™ of ₩19,469.96 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, T&R Biofab Co ranks worse than 97.61% on this metric.
The historical rank and industry rank for T&R Biofab Co's Days Payable or its related term are showing as below:
XKRX:246710'
s Days Payable Range Over the Past 10 Years
Min: 0.33 Med: 8.55 Max: 43.85
Current: 13.87
During the past 12 years, T&R Biofab Co's highest Days Payable was 43.85. The lowest was 0.33. And the median was 8.55.
XKRX:246710's Days Payable is ranked worse than 97.61% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.68
vs XKRX:246710: 13.87
T&R Biofab Co's Days Payable
declined
from Jun. 2025 (13.70) to Jun. 2026 (11.73).
It may suggest that T&R Biofab Coaccelerated paying its suppliers.
The historical data trend for T&R Biofab Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:246710 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, T&R Biofab Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T&R Biofab Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's Days Payable distribution charts can be found below:
* The bar in red indicates where T&R Biofab Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
T&R Biofab Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T&R Biofab Co (XKRX:246710) has a Days Payable of 11.73 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on T&R Biofab Co and its competitors. This is 37% above median its historical median of 8.55. Over the past decade, T&R Biofab Co's Days Payable has ranged from 0.33 to 43.85. According to the industry distribution chart, T&R Biofab Co ranks #777 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 97.6%.
Is T&R Biofab Co's Days Payable too high?
T&R Biofab Co's current Days Payable of 11.73 is 37% above median its 10-year median of 8.55. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 43.85. The Medical Devices & Instruments industry median Days Payable is 68.68. T&R Biofab Co's value of 11.73 is 82.9% below this industry median. Based on the distribution chart, T&R Biofab Co ranks #777 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, T&R Biofab Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does T&R Biofab Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, T&R Biofab Co ranks #777 out of 796 companies for Days Payable. This places T&R Biofab Co in the lower half of its industry. The industry median Days Payable is 68.68. T&R Biofab Co's value of 11.73 is 82.9% below this benchmark. Historically, T&R Biofab Co's own Days Payable has ranged from 0.33 to 43.85 over the past decade. While the company's 10-year median is 8.55 vs. the industry median of 68.68, T&R Biofab Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.68, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T&R Biofab Co's current Days Payable of 11.73 is 82.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on T&R Biofab Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T&R Biofab Co's current Days Payable is 11.73, which is 37% above median its own 10-year median of 8.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T&R Biofab Co stock overvalued right now?
Based on GuruFocus' analysis, T&R Biofab Co (XKRX:246710) is currently considered Possible Value Trap. The stock's GF Value™ is ₩19,469.96, compared to a current price of ₩2,200.00 — trading 88.7% below its estimated fair value. The current Days Payable is 11.73, which is 37% above median its 10-year median of 8.55 and 82.9% below the Medical Devices & Instruments industry median of 68.68. T&R Biofab Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For T&R Biofab Co (XKRX:246710), the current Days Payable is 11.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is T&R Biofab Co (XKRX:246710) Overvalued in 2026?
Based on GuruFocus' analysis, T&R Biofab Co stock appears to be undervalued.
The current stock price of ₩2,200.00 is trading 88.7% below its estimated GF Value™ of ₩19,469.96.
GuruFocus considers T&R Biofab Co to be Possible Value Trap.
Key valuation signals for XKRX:246710:
Days Payable: 11.73 (37% above median its 10-year median of 8.55)
GF Value™: ₩19,469.96 vs. price of ₩2,200.00 (88.7% below fair value)
Industry Position: 82.9% below the Medical Devices & Instruments median (#777 of 796)
No single metric tells the full story. See the XKRX:246710 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
57GF Score
Get the complete analysis for XKRX:246710
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246710 has been successfully added to your 
